Columbia Collaborative HIV/AIDS Clinical Trials Unit

$2,623,185UM1FY2024AINIH

Columbia University Health Sciences, New York NY

Investigators

Linked publications & trials

Paper 39587579 Paper 39399027 Paper 39265456 Paper 39225478 Paper 39204009 Paper 39119145 Paper 38947062 Paper 38913710 Paper 38911948 Paper 38868307 Paper 38854169 Paper 38831614 Paper 38827749 Paper 38801501 Paper 38794258 Paper 38780941 Paper 38770814 Paper 38645158 Paper 38643547 Paper 38630611 Paper 38598658 Paper 38562833 Paper 38381407 Paper 38366369 Paper 38331485 Paper 38306894 Paper 38270128 Paper 38260276 Paper 38191383 Paper 38160309 Paper 38019806 Paper 37956401 Paper 37921848 Paper 37802566 Paper 37676864 Paper 37533419 Paper 37440227 Paper 37439063 Paper 37399515 Paper 37385888 Paper 37352144 Paper 37350635 Paper 37315514 Paper 37315511 Paper 37251368 Paper 37126820 Paper 37071333 Paper 37070536 Paper 37010395 Paper 37003292 Paper 36925721 Paper 36912153 Paper 36899062 Paper 36891182 Paper 36869921 Paper 36846089 Paper 36692921 Paper 36649543 Paper 36630643 Paper 36610390 Paper 36580913 Paper 36540980 Paper 36539015 Paper 36525544 Paper 36454554 Paper 36374026 Paper 36348617 Paper 36255273 Paper 36205320 Paper 36131846 Paper 36106642 Paper 36094483 Paper 35995954 Paper 35961374 Paper 35921642 Paper 35903868 Paper 35895602 Paper 35642519 Paper 35562373 Paper 35486806 Paper 35438522 Paper 35378759 Paper 35289689 Paper 35139271 Paper 35086607 Paper 35018800 Paper 34797838 Paper 34687380 Paper 34642696 Paper 34554292 Paper 34506358 Paper 34441819 Paper 34430675 Paper 34229888 Paper 34185068 Paper 34166231 Paper 34110753 Paper 34099978 Paper 34083350 Paper 33993630

Abstract

The Columbia Collaborative HIV/AIDS Clinical Trials Unit (Columbia Collaborative CTU) brings together a dedicated and cohesive group of investigators and two institutions situated in New York City (NYC), one of the epicenters of the US epidemic. This collaboration includes highly experienced investigators and two successful clinical research sites (CRSs) with breadth and depth of expertise in clinical, translational and behavioral HIV research to be responsive to the rapidly evolving research needs in HIV prevention (including passive immunization with single, combination of multiple or multi-specific broadly neutralizing monoclonal antibodies, vaccines, novel antiretroviral-based approaches, and integrated biomedical and socio-behavioral strategies) and HIV therapeutics (including antibodies and long-acting antiretroviral formulations, and antiretroviral-free approaches to remission, biobehavioral interventions to improve adherence and reduce the risk of treatment failure, in addition to tuberculosis, complications and comorbidities), as defined by the Division of AIDS (DAIDS) Clinical Trials Networks (CTNs).

View original record on NIH RePORTER →